Home › Funds › Principal Global Investors › DYN
Principal Global Investors position in DYN
DYNE THERAPEUTICS INC · Health Care
Latest position (Q3 2024)7.50K sh
Reported value held$269.29K
Portfolio Weight0.00%
First reportedQ4 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 10.67K | $123.65K | New |
| Q1 2023 | 11.62K | $133.85K | Add |
| Q2 2023 | 13.75K | $154.72K | Add |
| Q3 2023 | 15.23K | $136.45K | Add |
| Q4 2023 | 14.55K | $193.46K | Reduce |
| Q1 2024 | 15.40K | $437.29K | Add |
| Q2 2024 | 13.77K | $485.98K | Reduce |
| Q3 2024 | 7.50K | $269.29K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DYN
- BlackRock Inc 12.40M sh · $275.50M · Q2 2026
- Fidelity Management & Research (FMR) 11.21M sh · $248.91M · Q2 2026
- Janus Henderson Group 13.65M sh · $247.43M · Q1 2026
- Vanguard Group 11.22M sh · $219.38M · Q4 2025
- Geode Capital Management 3.74M sh · $83.16M · Q2 2026
- JPMorgan Chase & Co 3.15M sh · $67.15M · Q2 2026
- Bank of America Corp 2.23M sh · $49.60M · Q2 2026
- Goldman Sachs Group 2.16M sh · $47.91M · Q2 2026
- Franklin Resources 2.03M sh · $45.10M · Q2 2026
- Marshall Wace 1.49M sh · $33.07M · Q2 2026
- Northern Trust Corp 1.28M sh · $28.39M · Q2 2026
- Charles Schwab Investment Management 1.20M sh · $26.70M · Q2 2026